LIFE SCIENCES | 卷:57 |
IDENTIFICATION OF A PRIMARY METABOLITE OF IBOGAINE THAT TARGETS SEROTONIN TRANSPORTERS AND ELEVATES SEROTONIN | |
Letter | |
MASH, DC ; STALEY, JK ; BAUMANN, MH ; ROTHMAN, RB ; HEARN, WL | |
关键词: 12-HYDROXYIBOGAMINE; SEROTONIN TRANSPORTERS; MICRODIALYSIS; DESMETHYL IBOGAINE; | |
DOI : 10.1016/0024-3205(95)00273-9 | |
来源: Elsevier | |
【 摘 要 】
Ibogaine is a hallucinogenic indole with putative efficacy for the treatment of cocaine, stimulant and opiate abuse. The purported efficacy of ibogaine following single dose administrations has led to the suggestion that a long-acting metabolite of ibogaine may explain in part how the drug reduces craving for psychostimulants and opiates. We report here that 12-hydroxyibogamine, a primary metabolite of ibogaine, displays high affinity for the 5-HT transporter and elevates extracellular 5-HT. In radioligand binding assays, 12-hydroxyibogamine was 50-fold more potent at displacing radioligand binding at the 5-HT transporter than at the DA transporter. Ibogaine and 12-hydroxyibogamine were equipotent at the dopamine transporter. In vivo microdialysis was used to evaluate the acute actions of ibogaine and 12-hydroxyibogamine on the levels of DA and 5-HT. Administration of 12-hydroxyibogamine produced a marked dose-related elevation of extracellular 5-HT. Ibogaine and 12-hydroxyibogamine failed to elevate DA levels in the nucleus accumbens over the dose range tested. The elevation in synaptic levels of 5-HT by 12-hydroxyibogamine may heighten mood and attenuate drug craving. The effects of the active metabolite on 5-HT transmission may account in part for the potential of ibogaine to interrupt drug-seeking behavior in humans.
【 授权许可】
Free
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
10_1016_0024-3205(95)00273-9.pdf | 559KB | download |